GP Vivas · haematological-presentations
Oral anticoagulation management — structured viva
Structured oral on oral anticoagulation: DOAC selection with trial numbers, the BRIDGE no-bridging revolution, mechanical valve territory per RE-ALIGN, renal dosing, switching rules and reversal agents.
On this page
Study tools
Target exams
RACGP CCEFRACGP oralsMRCGP SCA
Prompt
The examiner opens: 'Every anticoagulated patient needs heparin before surgery — that is what registrars are taught. Correct it.' The viva branches through BRIDGE, DOAC trial numbers, warfarin's last territory, and reversal.
Stem
You are the GP supervisor. Correct the teaching. [1]
References5ShowHide
- [1]Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation (BRIDGE) N Engl J Med, 2015.PMID 26095867
- [2]Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation (ARISTOTLE) N Engl J Med, 2011.PMID 21870978
- [3]Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation (ROCKET AF) N Engl J Med, 2011.PMID 21830957
- [4]Giugliano RP, Ruff CT, Braunwald E, et al. Edoxaban versus warfarin in patients with atrial fibrillation (ENGAGE AF-TIMI 48) N Engl J Med, 2013.PMID 24251359
- [5]Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves (RE-ALIGN) N Engl J Med, 2013.PMID 23991661